Sareum
GBX15
26
-GBX0.61-3.91% Thursday 14:39
Statistics
Day High
16.7
Day Low
15
52W High
29
52W Low
9.5
Volume
15,860
Avg. Volume
-
Mkt Cap
20.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
12MarExpected
Expected EPS
N/A
Actual EPS
-1.2107986944
Financials
-Profit Margin
Unprofitable0Revenue
-887.6MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow SAR.LSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Astrazeneca
AZN.LSE
Mkt Cap237.53B
GSK
GSK.LSE
Mkt Cap85.7B
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Merck
MRK
Mkt Cap298.84B
Pfizer
PFE
Mkt Cap161.09B
Roche
RHHBY
Mkt Cap321.08B
Novartis
NVS
Mkt Cap297.32B
AMGEN
AMGN
Mkt Cap187.56B
Lilly(Eli) &
LLY
Mkt Cap837.36B
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
About
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor which has completed Phase 1 clinical trial for the treatment of autoimmune diseases. It also develops SDC-1802, a TYK2/JAK1 inhibitor, that is in preclinical stage for cancer and cancer-immunotherapy applications; and SRA737, a clinical-stage oral, selective Chk 1 inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company has strategic collaboration with Receptor.AI launched in August 2025 to accelerate discovery and optimisation of BBB-permeable TYK2/JAK1 inhibitors; and completion of initial stage expected Q4 2025. Sareum Holdings plc was formerly known as Keepfast plc and changed its name to Sareum Holdings plc in July 2004. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Dr. Stephen Barry Parker DPhil, M.B.A., Ph.D.
Employees
5
Country
GB
ISIN
GB00BMC3RJ87
Listings
0 Comments
Share your thoughts
FAQ
What is Sareum stock price today?▼
The current price of SAR.LSE is GBX15 GBX — it has decreased by -3.91% in the past 24 hours. Watch Sareum stock price performance more closely on the chart.
What is Sareum stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sareum stocks are traded under the ticker SAR.LSE.
Is Sareum stock price growing?▼
SAR.LSE stock has risen by +0% compared to the previous week, the month change is a +12.57% rise, over the last year Sareum has showed a -16.67% decrease.
What is Sareum market cap?▼
Today Sareum has the market capitalization of 20.16M
When is the next Sareum earnings date?▼
Sareum is going to release the next earnings report on October 26, 2026.
What were Sareum earnings last quarter?▼
SAR.LSE earnings for the last quarter are -1.21 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Sareum revenue for the last year?▼
Sareum revenue for the last year amounts to 0 GBX.
What is Sareum net income for the last year?▼
SAR.LSE net income for the last year is -887.6M GBX.
How many employees does Sareum have?▼
As of April 10, 2026, the company has 5 employees.
In which sector is Sareum located?▼
Sareum operates in the Health Care sector.
When did Sareum complete a stock split?▼
The last stock split for Sareum was on March 01, 2022 with a ratio of 1:50.
Where is Sareum headquartered?▼
Sareum is headquartered in Cambridge, GB.